These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37739559)

  • 1. Phage therapy for Acinetobacter baumannii infection.
    Kaur R; Mandal D; Kumar A
    Prog Mol Biol Transl Sci; 2023; 200():303-324. PubMed ID: 37739559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics Act with vB_AbaP_AGC01 Phage against
    Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates.
    Jin J; Li ZJ; Wang SW; Wang SM; Huang DH; Li YH; Ma YY; Wang J; Liu F; Chen XD; Li GX; Wang XT; Wang ZQ; Zhao GQ
    BMC Microbiol; 2012 Jul; 12():156. PubMed ID: 22838726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.
    Ghaznavi-Rad E; Komijani M; Moradabadi A; Rezaei M; Shaykh-Baygloo N
    J Clin Lab Anal; 2022 Jul; 36(7):e24497. PubMed ID: 35708005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
    Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and Testing the Efficiency of
    Kusradze I; Karumidze N; Rigvava S; Dvalidze T; Katsitadze M; Amiranashvili I; Goderdzishvili M
    Front Microbiol; 2016; 7():1590. PubMed ID: 27757110
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical Assessment of Bacteriophage Therapy against Experimental
    Wienhold SM; Brack MC; Nouailles G; Krishnamoorthy G; Korf IHE; Seitz C; Wienecke S; Dietert K; Gurtner C; Kershaw O; Gruber AD; Ross A; Ziehr H; Rohde M; Neudecker J; Lienau J; Suttorp N; Hippenstiel S; Hocke AC; Rohde C; Witzenrath M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
    Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii.
    Mukhopadhyay S; Zhang P; To KKW; Liu Y; Bai C; Leung SSY
    Int J Antimicrob Agents; 2023 Nov; 62(5):106951. PubMed ID: 37574030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Phage-Based Cocktail and Antibiotic Combination Effects on
    Grygorcewicz B; Wojciuk B; Roszak M; Łubowska N; Błażejczak P; Jursa-Kulesza J; Rakoczy R; Masiuk H; Dołęgowska B
    Microb Drug Resist; 2021 Jan; 27(1):25-35. PubMed ID: 32543337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysin LysMK34 of
    Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and Characterization of a Novel
    Wintachai P; Surachat K; Singkhamanan K
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.
    Rao S; Betancourt-Garcia M; Kare-Opaneye YO; Swierczewski BE; Bennett JW; Horne B; Fackler J; Suazo Hernandez LP; Brownstein MJ
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0082421. PubMed ID: 34662188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii - a global health menace.
    Rai S; Kumar A
    Environ Microbiol Rep; 2022 Jun; 14(3):347-364. PubMed ID: 34196126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage.
    Sisakhtpour B; Mirzaei A; Karbasizadeh V; Hosseini N; Shabani M; Moghim S
    Ann Clin Microbiol Antimicrob; 2022 Jan; 21(1):1. PubMed ID: 34996464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.
    Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E
    Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.